. Cosinor analysis of A) systolic blood pressure and B) heart rate in control and Hsd11b2.BKO mice made from recordings over 5 consecutive days in each of the baseline, ad libitum and fixed salt phases. Mesor (mmHg); amplitude (mmHg) and acrophase (degrees) are shown as group arithmetic mean±SE;. The P values are 2-tailed and comparisons were made using unpaired t-tests.
Fixed salt intake
. A) sodium excretion, B) urine flow rate and C) potassium excretion in control mice (n=6; open circles) and Hsd11b2.BKO mice (n=6, black squares). Mice were fed a gel diet delivering a fixed sodium intake per day. For the first 5 days, mice received 0.1% Na diet before being fed 1% Na diet for the next 8 days. Data, normalized to body weight, are mean ± SEM. Two-way ANOVA with repeated measures was used to assess the main effects of salt diet and genotype and the interaction between these two. For sodium excretion, the effect of diet was significant (P<0.0001), the effect of genotype not significant (P=0.063) and the interaction significant (P=0.048). For urine flow rate the effect of diet (P<0.0001), genotype (P=0.004) and the interaction (P<0.0001) was significant. For potassium excretion the effect of diet (P<0.0001 and genotype (P=0.035) was significant; the interaction was not significant (P=0.837). No planned or post-hoc comparisons were made.
Supplemental Figure 7 . Baroreceptor reflex function under high salt conditions. The baroreflex was measured pharmacologically in anaesthetized Hsd11b2.BKO mice (black squares; n=5 mice/59 responses) and controls (white circles; n=6 mice; 71 responses) mice after 7 days of ad libitum access to 2.5% salt diet. A) the baroreflex curve showing individual data points for the change in heart rate (∆HR) in response to induced changes in systolic blood pressure (∆SBP). There was a significant difference (P<0.0001) between genotypes bylLinear regression analysis. B) the baroreflex gain during intravenous injection of sodium nitroprusside (tachycardic gain) and during C) intravenous injection of phenylephrine (bradycardic gain); individual data points are shown, with the median and IQR. Comparisons were by Mann-Whitney test, with P values as indicated. 
